🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with #checkpoint inhibitors Marie Kostine and colleagues ow.ly/umwl30qAPoy

#Laminuteduvendredi du 19 juin : Jules et Tanguy-Jim : PELLA-gre. J. met à profit ses qualités de musicien pour nous faire passer qq messages 🗝 sur la pellagre, maladie carentielle méconnue, sur l’air de Bella de Gims @MGimsOfficial ou Kendji 😊 lien : youtu.be/07RXENrXAGw

Voici les réponses de la Société française de rhumatologie aux questions des patients à propos de la vaccination Covid19. A diffuser++++ Merci de RT sfr.larhumatologie.fr/actualites/not…

Comme promis, #FuturInterne voici le thread sur la rhumato, cette spé que nous adorons.😍🥰 Essayer la rhumato, c’est l’adopter ! (1/9)

1/2 #pedagogy A tous les internes de 🇫🇷, de Navarre & d’ailleurs, un nouveau M2 ouvre à Université de Bordeaux avec Collège Santé - Université Bordeaux en nov. 2022, calé sur 1 année d’internat, destiné aux étudiants en santé, avec 3 axes, Infectiologie, Cancérologie & Inflammatoire. Maquette 👇🏼 Section REF

2/2 Lien du M2 👉🏼 formations.u-bordeaux.fr/#/details-form… Partagez-le ! Cecile Bebear Marie Kostine Maxime Mehlen @NGensous hannah kaminski Sébastien Hantz Sebastien Delescluse Amandine Gagneux-Brunon Elisabeth Botelho-Nevers Vincent Le Moing SNIO @ActuDentaire Florent Peyraud Marin Lahouati ANESF @RESEAUCHU

Very proud to share this review article freshly off the press in NatRevRheumatol. Opportunities and challenges of #ICI in patients with pre-existing #autoimmune disease. Still so much to learn! CHU de Bordeaux CHU Brest @HopitalEuropeen RESO Bordeaux nam12.safelinks.protection.outlook.com/?url=https%3A%…

join us Feb 9-10,2023, 4th annual Management of Checkpoint Inhibitor Related Toxicity conference Pauline Funchain Jame Abraham, MD, FACP @cappelliMD David Liew Anne Bass Jeffrey Sparks MD MMSc Nilasha Ghosh Pankti Reid Afreen Shariff, MD Rohit Moudgil MD PhD Ali Mehdi Bassam Estfan ccfcme.org/toxicitymgmt23

Updated📢 Management of toxicities from #immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment & follow-up. W/ recommended assessment & tx algorithms according to grade of toxicity ow.ly/K5nw50LcQyE John Haanen Wolfgang Wick 🇪🇺 Solange Peters Marie Kostine

🗓️#SaveTheDate : La 4e Journée RESO Bordeaux aura lieu le 9 mars 2023 ! Au programme : l’actualité de la recherche du #lupus, des #myosites et de la #sclérodermie ainsi qu’une session spéciale maladies auto-inflammatoires. reso-bordeaux.fr/save-the-date-… #maladieautoimmune #rhumatologie

Our #NovemberIssue is out now! Read about the role of #mitochondria in rheumatic diseases, immune-checkpoint inhibitors in patients with pre-existing #autoimmunity and sexual dimorphism in axial #spondyloarthritis go.nature.com/3SBB0xn

Congrats to the OMERACT irAE working group! First step of many to develop outcomes for ICI-induced arthritis patients! @RheumDr_Nina Marie Kostine Anne Bass @got_rheum @cappelliMD Cassandra Calabrese @

Fantastic team!

#NovemberIssue | Read about immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases in this #Review go.nature.com/3zaA2kY

David Liew will always inform and give a balanced view as well as his honest opinion. Follow him and others Dr. John Cush for coverage of #ACR22

Exciting project and fantastic team!

Big step in a highly complex area of checkpoint agonists-many more targets of interest from preclinical models PD-1 agonist generates ‘a bit of excitement’ in RA Max Konig David Liew Cassandra Calabrese Jeffrey Sparks MD MMSc Marie Kostine healio.com/news/rheumatol…

Great to meet pre-#EULAR2023 in person with fantastic rheumatic immune-related adverse events colleagues today. We keep working towards classification criteria, so we can get better treatments for our patients. Thanks to many great folks tagged, & led by Marie Kostine alexa meara

For our rheum patients who have had cancer previously - the default can’t be to not have DMARDs. EULAR points to consider SLR: no clear risk, across b/tsDMARDs For too long these patients were unnecessarily asked to ride it out. No more please POS1069 #EULAR2023 Dr. John Cush

Le type de troponine (I ou T) et les seuils pour stratifier les risques dans les #myocardites à l'#immunothérapie publié dans notre article paru Circulation ahajournals.org/doi/10.1161/CI… SABOURETCardiologist @AngoulvantD Pathak François Roubille Compte officiel du Réseau FR des CRPV Marie Kostine Jennifer Cautela